Regeneron Pharma Expects Slowing Eylea Sales, Shares Slip
February 09, 2016 at 08:06 AM EST
Regeneron Pharmaceuticals reported a weaker-than-expected profit for the first time in four quarters and forecast slowing sales growth for its blockbuster eye drug this year.